Genetic inactivation of NPC1L1 or inhibition with ezetimibe reduced blood phytosterols, inflammation, cardiac fibrosis, ventricular arrhythmias and sudden cardiac death. This evidence concerns the gene NPC1L1 and Ventricular arrhythmia.